Choi, H.J.; Ryu, J.M.; Lee, J.H.; Bang, Y.; Oh, J.; Chae, B.-J.; Nam, S.J.; Kim, S.W.; Lee, J.E.; Lee, S.K.;
et al. Is Pathologic Axillary Staging Valid If Lymph Nodes Are Less than 10 with Axillary Lymph Node Dissection after Neoadjuvant Chemotherapy? J. Clin. Med. 2022, 11, 6564.
https://doi.org/10.3390/jcm11216564
AMA Style
Choi HJ, Ryu JM, Lee JH, Bang Y, Oh J, Chae B-J, Nam SJ, Kim SW, Lee JE, Lee SK,
et al. Is Pathologic Axillary Staging Valid If Lymph Nodes Are Less than 10 with Axillary Lymph Node Dissection after Neoadjuvant Chemotherapy? Journal of Clinical Medicine. 2022; 11(21):6564.
https://doi.org/10.3390/jcm11216564
Chicago/Turabian Style
Choi, Hee Jun, Jai Min Ryu, Jun Ho Lee, Yoonju Bang, Jongwook Oh, Byung-Joo Chae, Seok Jin Nam, Seok Won Kim, Jeong Eon Lee, Se Kyung Lee,
and et al. 2022. "Is Pathologic Axillary Staging Valid If Lymph Nodes Are Less than 10 with Axillary Lymph Node Dissection after Neoadjuvant Chemotherapy?" Journal of Clinical Medicine 11, no. 21: 6564.
https://doi.org/10.3390/jcm11216564
APA Style
Choi, H. J., Ryu, J. M., Lee, J. H., Bang, Y., Oh, J., Chae, B.-J., Nam, S. J., Kim, S. W., Lee, J. E., Lee, S. K., & Yu, J.
(2022). Is Pathologic Axillary Staging Valid If Lymph Nodes Are Less than 10 with Axillary Lymph Node Dissection after Neoadjuvant Chemotherapy? Journal of Clinical Medicine, 11(21), 6564.
https://doi.org/10.3390/jcm11216564
